Susquehanna International Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.64M | Buy |
|
|||||
|
2025
Q1 | $1.02M | Buy |
|
|||||
|
2024
Q4 | $427K | Buy |
|
|||||
|
2024
Q3 | $470K | Sell |
|
|||||
|
2024
Q2 | $1.62M | Buy |
|
|||||
|
2024
Q1 | $411K | Buy |
|
|||||
|
2023
Q4 | $401K | Buy |
|
|||||
|
2023
Q3 | $283K | Buy |
|
|||||
|
2023
Q2 | $132K | Sell |
|
|||||
|
2023
Q1 | $1.84M | Buy |
|
|||||
|
2022
Q4 | $346K | Buy |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $284K | Sell |
|
|||||
|
2020
Q4 | $273K | Sell |
|
|||||
|
2020
Q3 | $739K | Sell |
|
|||||
|
2020
Q2 | $2.27M | Sell |
|
|||||
|
2020
Q1 | $1.66M | Sell |
|
|||||
|
2019
Q4 | $3.42M | Buy |
|
|||||
|
2019
Q3 | $1.3M | Buy |
|
|||||
|
2019
Q2 | $280K | Buy |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $243K | Buy |
|